Hospitals & Providers

Oncology Institute’s Dawn Holcombe, MBA, FACMPE, ACHE, shares her views on the OCM program, what CAR T-cell therapy means for the future of reimbursement, and some epic predictions.

How did Trump’s actions in 2017 impact the health insurance marketplace and enrollment numbers? Find out.

Pending and recently approved treatment options for patients with chronic obstructive pulmonary disease range from biologics to a triple-drug inhaler.

Willis Towers Watson research finds a dramatic increase among employers seeking to differentiate their health and well-being programs for competitive advantage.

With influenza activity increasing sharply, here’s how healthcare executives can determine which health plan members are at risk for the flu.

More reports of sexual harassment in the workplace are arising every day. It’s time to rethink your prevention strategies.

Trump’s new proposal would broaden access to association health plans. Here’s six things to know.

Managed Healthcare Executive board members identify top challenges. How does your list compare?

As the opioid epidemic rages, doctors and hospitals should consider these tips and strategies employed by other organizations.

More awareness and new state laws regarding end-of-life treatment are affecting treatment approaches. Here’s what you need to know.

The winds of change swept through healthcare in 2017. Here’s what 2018 could bring.

By recognizing and address the needs of the “whole person,” we have an opportunity to improve the health of people across the U.S. Here are two ways to do that.

With the right preventions in place, hospitals and healthcare executives will be well positioned to respond to these four risks in 2018.

A new survey has eye-opening findings about the status quo one-size-fits-all health plan.

Fifty percent of Americans have high blood pressure, per new guidelines. Here’s how those guidelines could affect medication utilization and healthcare spending.

Successful community initiatives are creating systems of care that bridge multiple programs to provide coordinated services to individuals with substance use disorders. Here are five.

A new report from Cardinal Health Specialty Solutions gives behind-the-scenes perspectives from oncologists about CAR-T cell therapies, biosimilars and AML therapies (or genomic medicines)

As 2017 comes to a close, how do healthcare leaders feel about the state of the industry? Here’s your chance to find out.

Simple strategies can improve the nutritional well-being of COPD patients and help them maintain their weight.

A Walgreens study sheds light on the benefits of patient-centered pharmacy-based programs.

The Innovation and Value Initiative's Mark Linthicum talks to Managed Healthcare Executive (MHE) a new tool to better measure value in healthcare treatments.

The Innovation and Value Initiative launched the Open-Source Value Project, creating tools that help payers, providers, and healthcare systems make informed and patient-centered decisions that produce better health outcomes.

A new study reveals interesting findings about improving the health of pediatric asthma patients and integrated care programs.

A new study reveals an important spillover effect of parental Medicaid coverage.

One expert says the interoperability of medical devices, especially of IoT medical devices, creates soft spots in an organization’s security framework.

A sneak peek at the findings from our 2018 Technology Survey reveal where healthcare organizations are struggling most when it comes to interoperability and Big Data.

Fitbit devices will be used for an NIH research program to explore the influence of behavioral, biological, and environmental influences on health.

If signed into law, Trump’s tax reform will have substantive impacts on healthcare organizations and on individuals.

Two new studies address the financial implications of unexpected major healthcare expenses for common cardiovascular conditions and procedures.

Healthcare executives have a unique leadership role to play in addressing the opioid crisis. Here’s what you need to do now.